Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

8.29
-0.7000-7.79%
Post-market: 8.28-0.0100-0.12%19:57 EDT
Volume:27.81M
Turnover:238.14M
Market Cap:3.76B
PE:-11.75
High:9.30
Open:9.08
Low:8.15
Close:8.99
52wk High:9.36
52wk Low:1.76
Shares:452.97M
Float Shares:394.00M
Volume Ratio:1.25
T/O Rate:7.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7058
EPS(LYR):-1.0941
ROE:-40.36%
ROA:-20.31%
PB:5.10
PE(LYR):-7.58

Loading ...

Iovance Biotherapeutics Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $71.430M Miss $78.396M Estimate

Benzinga Earnings
·
May 07

BRIEF-Iovance Biotherapeutics Q1 Revenue USD 71.43 Million

Reuters
·
May 07

Iovance Biotherapeutics Inc - Guides Q2 2026 Revenue $86 Mln-$88 Mln, FY2026 $350 Mln-$370 Mln

THOMSON REUTERS
·
May 07

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

GlobeNewswire
·
May 07

Earning Preview: Iovance Biotherapeutics, Inc. this quarter’s revenue is expected to decrease by 4.05%, and institutional views are bullish

Earnings Agent
·
May 01

Iovance Biotherapeutics to report first-quarter results, host conference call and webcast

Reuters
·
Apr 27

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

GlobeNewswire
·
Apr 27

Will FDA’s RP1 Setback Refocus Iovance Biotherapeutics' (IOVA) Post-Checkpoint Melanoma Narrative?

Simply Wall St.
·
Apr 22

Iovance grants 135,470 inducement stock options priced at $3.8 per share

Reuters
·
Apr 18

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 18

Iovance Biotherapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 18

Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Apr 11

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE) and Iovance Biotherapeutics (IOVA)

TIPRANKS
·
Apr 11

Replimune CRL positive for Iovance in near-term, says Chardan

TIPRANKS
·
Apr 11

Unusually active option classes on open April 10th

TIPRANKS
·
Apr 10

A Look At Iovance Biotherapeutics (IOVA) Valuation After Strong Amtagvi Data And Growing Pipeline Momentum

Simply Wall St.
·
Apr 09

Mizuho Securities Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)

TIPRANKS
·
Mar 30

Is Iovance Biotherapeutics (IOVA) Offering A Compelling Opportunity After Recent Price Swings?

Simply Wall St.
·
Mar 25

A Look At Iovance Biotherapeutics (IOVA) Valuation After Pipeline And Regulatory Updates At Barclays Healthcare Conference

Simply Wall St.
·
Mar 22

Iovance Biotherapeutics grants 3,400 inducement stock options at USD 3.87 exercise price

Reuters
·
Mar 21